Immediate Impact

2 by Nobel laureates 18 from Science/Nature 70 standout
Sub-graph 1 of 22

Citing Papers

Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Targeting protein–ligand neosurfaces with a generalizable deep learning tool
2025 StandoutNature
7 intermediate papers

Works of Paula Cramer being referenced

Second-line therapies of patients initially treated with fludarabine and cyclophosphamide or fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia within the CLL8 protocol of the German CLL Study Group
2013
Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
2011
and 7 more

Author Peers

Author Last Decade Papers Cites
Paula Cramer 1197 1035 441 72 1.5k
Florence Cymbalista 1232 934 489 81 1.7k
Nicole Lamanna 1336 1094 518 112 1.7k
Xavier C. Badoux 1110 945 449 60 1.3k
Cathy Zhou 1367 1127 486 42 1.4k
James P. Dean 1580 1088 483 59 1.7k
H Piguet 1394 1135 672 38 1.7k
Kerry A. Rogers 1088 857 396 121 1.3k
Karim Maloum 1195 907 611 50 1.6k
Manfred Hensel 952 878 511 67 1.5k
Ilaria Del Giudice 1450 1225 750 83 1.9k

All Works

Loading papers...

Rankless by CCL
2026